Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
Trial details
- Registry ID
- NCT06544798
- Phase
- Phase 2
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Long-term Follow-up of Gene Therapy for Radiation-Induced XerostomiaNCT06544798 | MeiraGTx, LLC | Phase 2 | Enrolling by invitation | 2032-02Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |